In summary, our results indicate that emodin inhibits TGF-β1 signaling pathway and subsequently suppresses fibroblast activation, EMT and eventual ECM deposition, thus leading to an improvement in BLM-induced pulmonary fibrosis and pulmonary function. Here, TGFB1 is linked to pulmonary fibrosis.